|
CH449645A
(de)
|
1963-07-09 |
1968-01-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Aminosäuren
|
|
JPS4940460Y2
(cg-RX-API-DMAC7.html)
|
1971-05-19 |
1974-11-06 |
|
|
|
US4087544A
(en)
|
1974-12-21 |
1978-05-02 |
Warner-Lambert Company |
Treatment of cranial dysfunctions using novel cyclic amino acids
|
|
DE2460891C2
(de)
|
1974-12-21 |
1982-09-23 |
Gödecke AG, 1000 Berlin |
1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US4123438A
(en)
|
1975-03-05 |
1978-10-31 |
Stamicarbon, B.V. |
Process for preparing 2-pyrrolidones
|
|
NZ194348A
(en)
|
1979-07-26 |
1982-09-14 |
Merrell Toraude & Co |
Fluorinated methyl-beta-alanine derivatives and pharmaceutical compositions
|
|
US4322440A
(en)
|
1980-06-25 |
1982-03-30 |
New York University |
Anticonvulsive compositions and method of treating convulsive disorders
|
|
US4513135A
(en)
|
1982-03-05 |
1985-04-23 |
Eli Lilly And Company |
Diaryl-pyrazine derivatives affecting GABA binding
|
|
DK373383A
(da)
|
1982-08-20 |
1984-02-21 |
Midit |
Fremgangsmaade til fremstilling af omega-aminosyrederivater
|
|
US4479005A
(en)
|
1982-12-16 |
1984-10-23 |
The Dow Chemical Company |
Selective preparation of isomers and enantiomers of cyclopropane carboxylic acids
|
|
DE133795T1
(de)
|
1983-08-01 |
1985-09-12 |
The Mclean Hospital Corp., Belmont, Mass. |
Gaba-ester und gaba-analoge ester.
|
|
US5051448A
(en)
|
1984-07-24 |
1991-09-24 |
The Mclean Hospital Corporation |
GABA esters and GABA analog esters
|
|
GB8425872D0
(en)
|
1984-10-12 |
1984-11-21 |
Ciba Geigy Ag |
Chemical compounds
|
|
DK170473B1
(da)
|
1985-06-20 |
1995-09-11 |
Daiichi Seiyaku Co |
S(-)-pyridobenzoxazinforbindelser
|
|
US4956388A
(en)
|
1986-12-22 |
1990-09-11 |
Eli Lilly And Company |
3-aryloxy-3-substituted propanamines
|
|
JP2535001B2
(ja)
|
1987-01-13 |
1996-09-18 |
ダイセル化学工業株式会社 |
Ｎ−アルキル化アミノ酸エステルの製法
|
|
JPH07116064B2
(ja)
|
1987-07-21 |
1995-12-13 |
三菱化学株式会社 |
分離剤
|
|
US4908210A
(en)
|
1988-10-28 |
1990-03-13 |
Eastman Kodak Company |
Lactylic salt tablet formulations and tablets
|
|
GB8911017D0
(en)
|
1989-05-13 |
1989-06-28 |
Ciba Geigy Ag |
Substituted aminoalkylphosphinic acids
|
|
DE3928183A1
(de)
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Lactamfreie cyclische aminosaeuren
|
|
GB8921304D0
(en)
|
1989-09-20 |
1989-11-08 |
Wyeth John & Brother Ltd |
New method of treatment and heterocyclic compounds used therein
|
|
US5104869A
(en)
|
1989-10-11 |
1992-04-14 |
American Cyanamid Company |
Renin inhibitors
|
|
US5084479A
(en)
|
1990-01-02 |
1992-01-28 |
Warner-Lambert Company |
Novel methods for treating neurodegenerative diseases
|
|
US5025035A
(en)
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
|
US6197819B1
(en)
|
1990-11-27 |
2001-03-06 |
Northwestern University |
Gamma amino butyric acid analogs and optical isomers
|
|
WO1992009560A1
(en)
|
1990-11-27 |
1992-06-11 |
Northwestern University |
Gaba and l-glutamic acid analogs for antiseizure treatment
|
|
WO1992014443A1
(en)
|
1991-02-20 |
1992-09-03 |
Warner-Lambert Company |
Microsphere-in-oil emulsion
|
|
DK204791D0
(da)
|
1991-12-20 |
1991-12-20 |
Novo Nordisk As |
Hidtil ukendt farmaceutisk praeparat
|
|
DE122004000039I2
(de)
*
|
1992-05-20 |
2006-06-29 |
Univ Northwestern |
Gaba und L-Glutaminsa}re analoga zur Behandlung der Epilepsie
|
|
GB9308430D0
(en)
|
1993-04-23 |
1993-06-09 |
Glaxo Group Ltd |
Medicaments
|
|
US5492927A
(en)
|
1993-12-21 |
1996-02-20 |
Eli Lilly And Company |
Non-peptide tachykinin receptor antagonists to treat allergy
|
|
US5652216A
(en)
|
1994-05-26 |
1997-07-29 |
Novo Nordisk A/S |
Pharmaceutical preparation
|
|
US5792796A
(en)
|
1994-07-27 |
1998-08-11 |
Warner-Lambert Company |
Methods for treating anxiety and panic
|
|
HU0102040D0
(en)
|
1994-07-27 |
2001-07-30 |
Warner Lambert Co |
Purified gabapentine binding protein
|
|
GB9420784D0
(en)
|
1994-10-14 |
1994-11-30 |
Glaxo Group Ltd |
Medicaments
|
|
US5767117A
(en)
|
1994-11-18 |
1998-06-16 |
The General Hospital Corporation |
Method for treating vascular headaches
|
|
EP0802912B1
(en)
|
1995-01-12 |
2004-10-13 |
Glaxo Group Limited |
Piperidine derivatives having tachykinin antagonist activity
|
|
WO1996026929A1
(en)
|
1995-02-28 |
1996-09-06 |
H. Lundbeck A/S |
4-aminotetrahydrobenzisoxazole or -isothiazole compounds
|
|
US5510381A
(en)
|
1995-05-15 |
1996-04-23 |
Warner-Lambert Company |
Method of treatment of mania and bipolar disorder
|
|
US5616793A
(en)
|
1995-06-02 |
1997-04-01 |
Warner-Lambert Company |
Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
|
|
US5637767A
(en)
|
1995-06-07 |
1997-06-10 |
Warner-Lambert Company |
Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
|
|
EA001534B1
(ru)
|
1996-02-07 |
2001-04-23 |
Варнер-Ламберт Компани |
Производные циклической аминокислоты или их фармацевтически приемлемые соли, фармацевтическая композиция и способ лечения депрессии, состояний паники, страха и болевых ощущений
|
|
BR9708200A
(pt)
|
1996-03-14 |
1999-07-27 |
Warner Lambert Co |
Aminoácidos cíclicos substituídos como agentes farmacéuticos
|
|
CZ287598A3
(cs)
|
1996-03-14 |
1999-02-17 |
Warner-Lambert Company |
Přemostěné cyklické aminokyseliny
|
|
US20020077461A1
(en)
|
1996-04-24 |
2002-06-20 |
Soren Bjorn |
Pharmaceutical formulation
|
|
US6372792B1
(en)
|
1996-04-26 |
2002-04-16 |
Guy Chouinard |
Method for treating anxiety, anxiety disorders and insomnia
|
|
US5998435A
(en)
|
1996-06-26 |
1999-12-07 |
Warner-Lambert Company |
Use of a tachykinin antagonist for the manufacture of a medicament for the treatment of emesis
|
|
SE9603408D0
(sv)
|
1996-09-18 |
1996-09-18 |
Astra Ab |
Medical use
|
|
US6329429B1
(en)
|
1997-06-25 |
2001-12-11 |
Warner-Lambert Company |
Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
|
|
HRP980342A2
(en)
|
1997-06-25 |
1999-02-28 |
Warner Lambert Co |
Anti-inflammatory method
|
|
US6194459B1
(en)
|
1997-08-19 |
2001-02-27 |
Warner-Lambert Company |
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
|
|
US6127418A
(en)
|
1997-08-20 |
2000-10-03 |
Warner-Lambert Company |
GABA analogs to prevent and treat gastrointestinal damage
|
|
WO1999008670A1
(en)
|
1997-08-20 |
1999-02-25 |
Guglietta, Antonio |
Gaba analogs to prevent and treat gastrointestinal damage
|
|
ATE311867T1
(de)
|
1997-09-08 |
2005-12-15 |
Warner Lambert Co |
Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen
|
|
NZ503981A
(en)
|
1997-12-16 |
2002-12-20 |
Warner Lambert Co |
Novel amines, pharmaceutical compositions containing these amines, and uses thereof
|
|
PL204921B1
(pl)
|
1998-05-15 |
2010-02-26 |
Warner Lambert Co |
Stabilizowana kompozycja farmaceutyczna zawierająca 4-amino-3-podstawioną pochodną kwasu butanowego i α-aminokwas oraz sposób jej wytwarzania
|
|
KR100669280B1
(ko)
|
1998-05-15 |
2007-01-17 |
워너-램버트 캄파니 엘엘씨 |
감마-아미노부티르산 유도체 포함 고상 조성물 및 그의제조 방법
|
|
CA2332915C
(en)
|
1998-07-09 |
2006-10-24 |
Warner-Lambert Company |
Compositions comprising gaba analogs and caffeine
|
|
US20030045500A1
(en)
|
1998-07-09 |
2003-03-06 |
Leslie Magnus |
Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
|
|
WO2000002546A2
(en)
|
1998-07-09 |
2000-01-20 |
Warner-Lambert Company |
Use of caba-analogues for treating insomnia
|
|
US6680343B1
(en)
|
1998-07-09 |
2004-01-20 |
Warner-Lambert Comapny |
Treatment of renal colic with GABA analogs
|
|
EP1121114B1
(en)
|
1998-10-16 |
2007-01-10 |
Warner-Lambert Company Llc |
Use of gaba analogs for the manufacture of a medicament for the treatment of mania and bipolar disorders
|
|
JP2002538221A
(ja)
|
1999-03-10 |
2002-11-12 |
ワーナー−ランバート・カンパニー |
抗てんかん作用を有する化合物を包含する鎮痛組成物およびその使用方法
|
|
US6992109B1
(en)
|
1999-04-08 |
2006-01-31 |
Segal Catherine A |
Method for the treatment of incontinence
|
|
AU3492900A
(en)
|
1999-04-09 |
2000-11-14 |
Warner-Lambert Company |
Combinations of gaba analogs and tricyclic compounds to treat depression
|
|
CA2371395A1
(en)
|
1999-06-02 |
2000-12-07 |
Warner Lambert Company |
Amino heterocycles useful as pharmaceutical agents
|
|
US6642398B2
(en)
|
1999-06-10 |
2003-11-04 |
Warner-Lambert Company |
Mono-and disubstituted 3-propyl gamma-aminobutyric acids
|
|
US7164034B2
(en)
|
1999-06-10 |
2007-01-16 |
Pfizer Inc. |
Alpha2delta ligands for fibromyalgia and other disorders
|
|
CA2373953A1
(en)
|
1999-07-02 |
2001-01-11 |
Warner-Lambert Company |
A synergistic combination: gabapentin and pregabalin
|
|
US7030119B1
(en)
|
1999-07-16 |
2006-04-18 |
Warner-Lambert Company |
Method for treating chronic pain using MEK inhibitors
|
|
BR0014090A
(pt)
|
1999-09-16 |
2002-05-21 |
Warner Lambert Co |
Método para rastreamento de ligandos de ligação à subunidade alfa2delta-1
|
|
AP2002002501A0
(en)
|
1999-10-07 |
2002-06-30 |
Warner Lambert Co |
Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
|
|
PT1250311E
(pt)
|
2000-01-27 |
2004-07-30 |
Warner Lambert Co |
Sintese assimetrica de pregabalina
|
|
US20010036943A1
(en)
|
2000-04-07 |
2001-11-01 |
Coe Jotham W. |
Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
|
|
AU2001259627A1
(en)
|
2000-05-16 |
2001-11-26 |
Warner Lambert Company |
Cell line for the expression of an alpha2delta2 calcium channel subunit
|
|
GB2365425A
(en)
|
2000-08-01 |
2002-02-20 |
Parke Davis & Co Ltd |
Alkyl amino acid derivatives useful as pharmaceutical agents
|
|
CA2356829A1
(en)
|
2000-09-22 |
2002-03-22 |
Warner-Lambert Company |
Method for treating asthma using pregabalin
|
|
US6620829B2
(en)
|
2000-10-17 |
2003-09-16 |
Warner-Lambert Company |
Method of treating noninflammatory cartilage damage
|
|
PT1337271E
(pt)
|
2000-11-30 |
2005-01-31 |
Pfizer Prod Inc |
Combinacao de agonistas de gaba e inibidores de sorbitol desidrogenase
|
|
PL365378A1
(en)
|
2000-11-30 |
2005-01-10 |
Pfizer Products Inc. |
Combination of gaba agonists and aldose reductase inhibitors
|
|
CA2428778A1
(en)
|
2000-12-13 |
2002-06-20 |
Warner-Lambert Company Llc |
P-chirale bisphospholane ligands, their transition metal complexes
|
|
US20040002543A1
(en)
|
2001-02-16 |
2004-01-01 |
Leslie Magnus |
Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain
|
|
DE60204611T2
(de)
|
2001-02-28 |
2006-05-11 |
Pfizer Products Inc., Groton |
Sulfonyl-pyridazinon-derivate zur Verwendung als Aldose-reduktase-inhibitoren
|
|
MXPA02001147A
(es)
|
2001-03-19 |
2004-04-21 |
Warner Lambert Co |
Sintesis de ligandos bisfosina no-c2-simetricos como catalizadores para la hidrogenacion asimetrica.
|
|
EP1247809A3
(en)
|
2001-03-30 |
2003-12-17 |
Pfizer Products Inc. |
Triazine compounds useful as sorbitol dehydrogenase inhibitors
|
|
PT1373259E
(pt)
|
2001-03-30 |
2005-03-31 |
Pfizer Prod Inc |
Inibidores piridazinona de aldose reductase
|
|
US7022678B2
(en)
|
2001-03-30 |
2006-04-04 |
Warner-Lambert Company |
Pregabalin lactose conjugates
|
|
OA12504A
(en)
|
2001-04-19 |
2006-05-29 |
Warner Lambert Co |
Fused bicyclic or tricyclic amino acids.
|
|
MXPA03009392A
(es)
|
2001-05-25 |
2004-01-29 |
Warner Lambert Co |
Composicion famaceutica liquida.
|
|
US20030045449A1
(en)
|
2001-08-15 |
2003-03-06 |
Pfizer, Inc. |
Pharmaceutical combinations for the treatment of neurodegenerative diseases
|
|
DE10203122A1
(de)
|
2002-01-25 |
2003-07-31 |
Gruenenthal Gmbh |
Verfahren zur Herstellung von substituierten Acrylsäureestern bzw. deren Einsatz zur Herstellung von substituierten gamma-Aminosäuren
|
|
NZ532624A
(en)
|
2002-01-31 |
2007-05-31 |
Warner Lambert Co |
Alpha2delta ligands to treat tinnitus
|
|
US6855724B2
(en)
|
2002-04-08 |
2005-02-15 |
Agouron Pharmaceuticals, Inc. |
Tropane derivatives useful in therapy
|
|
US6713490B2
(en)
|
2002-04-26 |
2004-03-30 |
Pfizer, Inc. |
3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
|
|
US20030225149A1
(en)
|
2002-04-30 |
2003-12-04 |
Blazecka Peter G. |
Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
|
|
JP2005534678A
(ja)
|
2002-06-27 |
2005-11-17 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
注意欠陥多動性障害の治療方法
|
|
CA2491994C
(en)
|
2002-07-08 |
2013-11-05 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
|
US7053122B2
(en)
|
2002-08-09 |
2006-05-30 |
Pfizer Inc |
Therapeutic use of aryl amino acid derivatives
|
|
US7419981B2
(en)
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
US20040092522A1
(en)
|
2002-08-15 |
2004-05-13 |
Field Mark John |
Synergistic combinations
|
|
US7071339B2
(en)
|
2002-08-29 |
2006-07-04 |
Warner Lambert Company Llc |
Process for preparing functionalized γ-butyrolactones from mucohalic acid
|
|
US7659305B2
(en)
|
2002-10-31 |
2010-02-09 |
Pfizer Inc. |
Therapeutic proline derivatives
|
|
BR0316386A
(pt)
|
2002-12-06 |
2005-09-27 |
Warner Lambert Co |
Benzoxazin-3-onas e seus derivados como inibidores de p13k
|
|
PL377662A1
(pl)
|
2002-12-13 |
2006-02-06 |
Warner-Lambert Company Llc |
Pregabalina i jej pochodne w leczeniu fibromialgii i innych zaburzeń pokrewnych
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
US7572910B2
(en)
|
2003-02-20 |
2009-08-11 |
Pfizer, Inc. |
Pyridazinone aldose reductase inhibitors
|
|
AU2004237951A1
(en)
|
2003-05-16 |
2004-11-25 |
Pfizer Products Inc. |
Therapeutic combinations of atypical antipsychotics with GABA modulators, anticonvulsants or benzodiazapines
|
|
EP1644360A1
(en)
|
2003-06-05 |
2006-04-12 |
Warner-Lambert Company LLC |
3-substituted indoles and derivatives thereof as therapeutic agents
|
|
WO2005002585A1
(en)
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
|
OA13248A
(en)
|
2003-09-03 |
2007-01-31 |
Pfizer |
Benzimidazolone coumpounds having 5-HT4 receptor agonistic activity.
|
|
CA2537402C
(en)
|
2003-09-12 |
2009-05-05 |
Pfizer Inc. |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
|
|
CA2538412A1
(en)
|
2003-09-12 |
2005-03-24 |
Warner-Lambert Company Llc |
Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders
|
|
GB0322140D0
(en)
|
2003-09-22 |
2003-10-22 |
Pfizer Ltd |
Combinations
|
|
BRPI0414819A
(pt)
|
2003-09-25 |
2006-11-14 |
Warner Lambert Co |
pró-fármacos de aminoácidos com afinidade para a proteìna alfa2delta
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
EP1543831A1
(en)
|
2003-12-18 |
2005-06-22 |
Pfizer GmbH Arzneimittelwerk Gödecke |
Pregabalin composition
|
|
WO2005082372A1
(en)
|
2004-01-29 |
2005-09-09 |
Pfizer Products Inc. |
COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
|
|
GB0405200D0
(en)
|
2004-03-08 |
2004-04-21 |
Pfizer Ltd |
Combinations comprising alpha-2-delta ligands
|
|
BRPI0508615A
(pt)
|
2004-03-12 |
2007-07-31 |
Warner Lambert Co |
lingandos de bisfosfina c1-simétrica e seu emprego na sìntese assimétrica de pregabalina
|
|
US7354925B2
(en)
|
2004-03-29 |
2008-04-08 |
Pfizer Inc. |
Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists
|
|
ATE405572T1
(de)
|
2004-04-01 |
2008-09-15 |
Warner Lambert Co |
Herstellung von p-chirogenen phospholanen und deren verwendung in der asymmetrischen synthese
|
|
BRPI0509731A
(pt)
|
2004-04-07 |
2007-09-25 |
Pfizer |
pirazol[4,3-d]pirimidinas
|
|
UA82292C2
(uk)
|
2004-04-14 |
2008-03-25 |
Пфайзер Продактс Инк. |
Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
|
|
CN1946391A
(zh)
|
2004-04-20 |
2007-04-11 |
辉瑞产品公司 |
包含α－2－δ配体的组合
|
|
JP2007533725A
(ja)
|
2004-04-20 |
2007-11-22 |
ファイザー・インク |
Ｃｒｔｈ２受容体アンタゴニストを用いたニューロパシー性疼痛処置方法
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
GEP20084550B
(en)
|
2004-04-30 |
2008-11-25 |
Warner Lambert Co |
Substituted morpholine compounds for the treatment of central nervous system disorders
|
|
US7737163B2
(en)
|
2004-06-15 |
2010-06-15 |
Pfizer Inc. |
Benzimidazolone carboxylic acid derivatives
|
|
AU2005254800B2
(en)
|
2004-06-15 |
2010-12-09 |
Pfizer Inc. |
Benzimidazolone carboxylic acid derivatives
|
|
EA200800909A1
(ru)
|
2004-06-21 |
2008-08-29 |
УОРНЕР-ЛАМБЕРТ КОМПАНИ ЭлЭлСи |
Получение прегабалина и родственных соединений
|
|
EP1776352A1
(en)
|
2004-06-29 |
2007-04-25 |
Pfizer Products Inc. |
Method for preparing 5-[4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h[1,2,4]triazin-2-yl]-benzamide derivatives by deprotecting the hydroxyl-protected precursers
|
|
US20060003344A1
(en)
|
2004-06-30 |
2006-01-05 |
Pfizer Inc. |
Methods related to a single nucleotide polymorphism of the G protein coupled receptor, GPR40
|
|
WO2006008640A1
(en)
|
2004-07-15 |
2006-01-26 |
Pharmacia & Upjohn Company Llc |
Non-aqueous suspension containing a drug having an unpleasant taste
|
|
EA200700099A1
(ru)
|
2004-07-23 |
2007-08-31 |
Пфайзер Инк. |
Производные пиридина
|
|
GB0419849D0
(en)
|
2004-09-07 |
2004-10-13 |
Pfizer Ltd |
Pharmaceutical combination
|
|
WO2006048754A1
(en)
|
2004-11-02 |
2006-05-11 |
Pfizer Japan Inc. |
Sulfonyl benzimidazole derivatives
|
|
CN101087771A
(zh)
|
2004-11-10 |
2007-12-12 |
辉瑞大药厂 |
经取代n－磺酰基氨基苄基－2－苯氧基乙酰胺化合物
|
|
US7122683B2
(en)
|
2004-11-23 |
2006-10-17 |
Pfizer Inc. |
Amides useful as monoamine re-uptake inhibitors
|
|
DE602005019913D1
(de)
|
2004-11-29 |
2010-04-22 |
Warner Lambert Co |
Therapeutische pyrazoloä3,4-büpyridine und -indazole
|
|
GEP20094727B
(en)
|
2005-02-22 |
2009-07-10 |
Pfizer |
Oxyindole derivatives as 5ht4 receptor agonists
|
|
WO2006092692A1
(en)
|
2005-03-01 |
2006-09-08 |
Pfizer Limited |
Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
|
|
WO2006095263A1
(en)
|
2005-03-10 |
2006-09-14 |
Pfizer Japan Inc. |
Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
|
|
AU2006224295A1
(en)
|
2005-03-17 |
2006-09-21 |
Pfizer, Inc. |
N- (N-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain
|
|
JP2008536910A
(ja)
|
2005-04-20 |
2008-09-11 |
ファイザー・リミテッド |
プロゲステロン受容体アンタゴニストとしてのピラゾール誘導体
|
|
KR100925900B1
(ko)
|
2005-04-28 |
2009-11-09 |
화이자 리미티드 |
아미노산 유도체
|
|
US20080269310A1
(en)
|
2005-05-20 |
2008-10-30 |
Adrian Paul Foster |
Synergistic Combinations
|
|
EP1893583B1
(en)
|
2005-05-31 |
2012-04-04 |
Pfizer Inc. |
Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
|
|
NL2000281C2
(nl)
|
2005-11-02 |
2007-08-07 |
Pfizer Prod Inc |
Vaste farmaceutische samenstellingen die pregabaline bevatten.
|
|
NL2000284C2
(nl)
|
2005-11-04 |
2007-09-28 |
Pfizer Ltd |
Pyrazine-derivaten.
|
|
WO2007054770A2
(en)
|
2005-11-08 |
2007-05-18 |
Pfizer Limited |
Pyrazole derivatives and their medical use
|
|
AP2008004470A0
(en)
|
2005-12-02 |
2008-06-30 |
Pfizer Ltd |
Spirocyclic quinazoline derivatives as pde7 inhibitors
|
|
CA2530904C
(en)
|
2005-12-20 |
2013-10-08 |
John Marino |
Pharmaceutical agents for the treatment of pain associated with spinal cord injury
|
|
CN101420947A
(zh)
|
2006-03-06 |
2009-04-29 |
辉瑞产品公司 |
用于非恢复性睡眠的α-2-δ配体
|
|
GB0700786D0
(en)
|
2007-01-15 |
2007-02-21 |
Pfizer Ltd |
Morpholine dopamine agonists for the treatment of pain
|
|
PT2114970E
(pt)
|
2007-02-02 |
2011-09-22 |
Pfizer Prod Inc |
Compostos tricíclicos e sua utilização como moduladores de receptor de glucocorticóide
|
|
WO2008132589A1
(en)
|
2007-05-01 |
2008-11-06 |
Pfizer Limited |
Combinations comprising pregabalin
|